1. Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes.
- Author
-
Baldane S, Ipekci SH, Ekin A, Abusoglu S, Unlu A, and Kebapcilar L
- Subjects
- Fasting, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Blood Glucose metabolism, Chemokine CX3CL1 metabolism, Diabetes Mellitus, Type 2 metabolism, Glucose Intolerance metabolism, Prediabetic State metabolism, Proto-Oncogene Proteins metabolism
- Abstract
Objective: The objective of this study is to compare serum levels of FKN and SFRP-4 in patients with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and type 2 diabetes mellitus (T2DM)., Methods: A total of 152 patients presented to the endocrinology outpatient clinic of our hospital were included in the study. Eighty-two patients with a history of T2DM were assigned to the T2DM group. IGT (n = 34) and NGT (n = 36) groups included the patients who received oral glucose tolerance test outcomes., Results: Serum FKN levels were significantly higher in the IGT and T2DM groups compared to the NGT group (p < 0.001 and p < 0.001, respectively). Serum SFRP-4 levels were significantly higher in the T2DM group compared to the IGT and NGT groups (p = 0.001 and p = 0.004, respectively). A significant correlation was observed between FKN and fasting glucose levels. SFRP-4 was significantly correlated with fasting glucose, HbA1c, and triglyceride levels., Conclusion: To our knowledge, increased FKN levels in patients with IGT were demonstrated for the first time in this study. The results of our study support the opinion that FKN and SFRP-4 may contribute to the pathogenesis of T2DM (Tab. 1, Fig. 3, Ref. 23).
- Published
- 2018
- Full Text
- View/download PDF